Clinical Trial Update: Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD [Phase 2]

View source ↗

Summary

Phase 2 trial assessing intradiscal autologous bone marrow-derived mesenchymal stem cell injections for chronic low back pain due to multilevel intervertebral d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intervertebral Disc Degeneration
• Low Back Pain

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stem cells (BM-MSCs) intradiscal injection (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico | Conditions: Intervertebral Disc Degeneration, Chronic Low-back Pain | Phase 2 | Status: RECRUITING